Details for Patent: 10,603,280
✉ Email this page to a colleague
Which drugs does patent 10,603,280 protect, and when does it expire?
Patent 10,603,280 protects CRESEMBA and is included in one NDA.
Protection for CRESEMBA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eight patent family members in seven countries.
Summary for Patent: 10,603,280
Title: | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof |
Abstract: | The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate. |
Inventor(s): | Gruber; Peter (Merzhausen, DE), Spickermann; Dirk (Staufen, DE) |
Assignee: | Losan Pharma GmbH (Neuenburg, DE) |
Application Number: | 16/213,655 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; | More… ↓ |
Drugs Protected by US Patent 10,603,280
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | CRESEMBA | isavuconazonium sulfate | CAPSULE;ORAL | 207500-002 | Nov 22, 2022 | RX | Yes | No | 10,603,280*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Astellas | CRESEMBA | isavuconazonium sulfate | CAPSULE;ORAL | 207500-001 | Mar 6, 2015 | RX | Yes | Yes | 10,603,280*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,603,280
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
06020008 | Sep 25, 2006 |
International Family Members for US Patent 10,603,280
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | E459342 | ⤷ Subscribe | |||
Australia | 2007302320 | ⤷ Subscribe | |||
Canada | 2663941 | ⤷ Subscribe | |||
Germany | 502007003037 | ⤷ Subscribe | |||
Denmark | 2068842 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |